MedPath

Supporting looked after children and care leavers in decreasing drugs and alcohol

Not Applicable
Completed
Conditions
Risky substance use (drugs and alcohol)
Mental and Behavioural Disorders
Risky substance use
Registration Number
ISRCTN80786829
Lead Sponsor
ewcastle University
Brief Summary

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28536655 protocol 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30791874 Phase 1 results (added 27/01/2020) 2019 Other publications in https://doi.org/10.1111/hex.12904 (added 10/07/2023) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31005828/ (added 10/07/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32898141/ (added 10/07/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32960519/ (added 10/07/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. Looked Children and Care Leavers aged =12 and =20 years
2. Screen positive for being at risk of substance misuse i.e. scoring =2 on the CRAFFT
3. Informed consent given: LAC under 16 years consent from parent/guardian (local authority) and assent from young person; LAC 16 years and over consent from young person

Exclusion Criteria

1. Already in active treatment with drug and alcohol services
2. Unable to access drug and alcohol services e.g. due to imminent move out of area
3. Unable to give informed consent in English

It should be noted that the intervention is delivered in English. The numbers of young people excluded due to language barriers will be reviewed for the definitive RCT.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Episodes of heavy episodic drinking (=5 units in 1 day), measured using the Timeline Follow- back Questionnaire, which considers the preceding 7 day and 30 day period<br>2. Frequency of use of the most problematic classified substance using the Timeline Follow-back questionnaire (7 and 30 day)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath